Manganese suppresses the development of oral leukoplakia by activating the immune response
Manganese suppresses the development of oral leukoplakia by activating the immune response
复制标题
锰通过激活免疫反应抑制口腔白斑的发展
DOI:
10.1111/odi.14412
复制
发表时间:
2022-11-21
期刊:
影响因子:
3.8
通讯作者:
Zeng,Xin
中科院分区:
文献类型:
--
作者:
Shi,Yujie;Su,Chongying;Zeng,Xin
ObjectiveManganese ion (Mn2+) is reported to promote the antitumor immune response by activating the cGAS‐STING pathway, but it is unknown whether Mn2+can prevent the malignant transformation of precancerous lesions. The effects of Mn2+in treating oral leukoplakia (OLK) were explored in this work.MethodsPeripheral blood Mn analysis of the patients was performed using inductively coupled plasma atomic emission spectroscopy (ICP–AES). A coculture model of dendritic cells (DCs)/macrophages, CD8+T cells, and dysplastic oral keratinocytes (DOKs) was employed to analyze the role and mechanism of Mn2+in a simulated OLK immune microenvironment. Western blot, RT–PCR, flow cytometry, enzyme‐linked immunosorbent assay (ELISA), and lactate dehydrogenase (LDH) assays were adopted to detect the mechanism of Mn2+in this model. 4‐nitroquinoline oxide (4NQO)‐induced OLK mice were used to assess the role of Mn2+in suppressing OLK progression, and a novel Mn2+‐loaded guanosine‐tannic acid hydrogel (G‐TA@Mn2+hydrogel) was fabricated and evaluated for its advantages in OLK therapy.ResultsThe content of Mn in patients' peripheral blood was negatively related to the progression of OLK. Mn2+promoted the maturation and antigen presentation of DCs and macrophages and enhanced the activation of CD8+T cells in the coculture model, resulting in effective killing of DOKs. Mechanistic analysis found that Mn2+enhanced the anti‐OLK immune response by activating the cGAS‐STING pathway. Moreover, Mn2+suppressed the development of 4NQO–induced carcinogenesis in the mouse model. In addition, the G‐TA@Mn2+hydrogel had better anti‐OLK effects.ConclusionsMn2+enhanced the anti‐OLK immune response by activating the cGAS‐STING pathway, and the G‐TA@Mn2+hydrogel is a potential novel therapeutic approach for OLK treatment.